BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 11118323)

  • 1. Stable lentiviral transformation of CHO cells for the expression of the hemagglutinin H5 of avian influenza virus in suspension culture.
    Pose AG; Morell NO; Matos DA; Rodríguez ER; Rodríguez ES; Cordero LR; Moltó MPR; Ramos EMG; Gutiérrez AÁ; Pérez LG; Gómez JN; Redondo AV; Nordelo CB
    Biotechnol Rep (Amst); 2014 Sep; 3():108-116. PubMed ID: 28626654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonviral DNA vectors for immunization and therapy: design and methods for their obtention.
    Rodríguez EG
    J Mol Med (Berl); 2004 Aug; 82(8):500-9. PubMed ID: 15175860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera.
    Chikhlikar P; Barros de Arruda L; Agrawal S; Byrne B; Guggino W; August JT; Marques ET
    Virology; 2004 Jun; 323(2):220-32. PubMed ID: 15193918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates.
    Shen S; Wang S; Britt WJ; Lu S
    Vaccine; 2007 Apr; 25(17):3319-27. PubMed ID: 17287056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of immune response in mice to plasmid DNA encoding human sperm associated antigen 9 (SPAG9).
    Jagadish N; Rana R; Mishra D; Garg M; Selvi R; Suri A
    Vaccine; 2006 Apr; 24(17):3695-703. PubMed ID: 16061308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of DNA vaccine immunogenicity by a dual antigen expression system.
    Sasaki S; Takeshita F; Oikawa T; Kojima Y; Xin KQ; Okuda K; Ishii N
    Biochem Biophys Res Commun; 2004 Feb; 315(1):38-43. PubMed ID: 15013422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of DNA vaccine-induced immune responses by a 72-bp element from SV40 enhancer.
    Li HS; Liu Y; Li DF; Zhang RR; Tang HL; Zhang YW; Huang W; Liu Y; Peng H; Xu JQ; Hong KX; Shao YM
    Chin Med J (Engl); 2007 Mar; 120(6):496-502. PubMed ID: 17439744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A family of compact plasmid vectors for DNA immunization in humans.
    Herrera AM; Rodríguez EG; Hernández T; Sández B; Duarte CA
    Biochem Biophys Res Commun; 2000 Dec; 279(2):548-51. PubMed ID: 11118323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Main features of DNA-based immunization vectors.
    Azevedo V; Levitus G; Miyoshi A; Cândido AL; Goes AM; Oliveira SC
    Braz J Med Biol Res; 1999 Feb; 32(2):147-53. PubMed ID: 10347749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in the design of viral vaccines.
    Minor PD
    Dev Biol Stand; 1996; 87():51-7. PubMed ID: 8854002
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification of plasmids for gene therapy and DNA vaccination.
    Prazeres DM; Monteiro GA; Ferreira GN; Diogo MM; Ribeiro SC; Cabral JM
    Biotechnol Annu Rev; 2001; 7():1-30. PubMed ID: 11686041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.
    Williams JA; Carnes AE; Hodgson CP
    Biotechnol Adv; 2009; 27(4):353-70. PubMed ID: 19233255
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.